Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
Cardinal Health raises full-year profit forecast on specialty drug strength
00

Cardinal Health raises full-year profit forecast on specialty drug strength

Aug 11, 2026

On August 11, 2026, Cardinal Health forecast fiscal 2027 adjusted profit between $12.40 and $12.60 per share, topping Wall Street expectations of $12.04. The distributor reported fourth-quarter adjusted profit of $2.91 per share, beating estimates of $2.42, driven by strong specialty drug demand. Revenue rose 6% to $63.67 billion, missing estimates. Cardinal Health also announced $1 billion in planned fiscal 2027 share repurchases and highlighted its recent $360 million home care acquisitions.

Cardinal Health profit forecast raise

  • ▪Cardinal Health's total fourth-quarter revenue rose 6% to $63.67 billion, missing analysts' average expectations of $65.03 billion
  • ▪Cardinal Health announced on August 11, 2026, that the company expects to execute $1 billion in share repurchases during fiscal year 2027
  • ▪Cardinal Health shares rose over 4% in premarket trading on August 11, 2026, following the company's profit forecast announcement
  • ▪Cardinal Health's fiscal 2027 adjusted profit forecast of $12.40 to $12.60 per share exceeded analysts' average expectations of $12.04 per share
  • ▪Cardinal Health forecast fiscal 2027 adjusted profit per share between $12.40 and $12.60 on August 11, 2026
  • ▪Cardinal Health reported an adjusted fourth-quarter profit of $2.91 per share, beating analysts' average estimates of $2.42 per share

Specialty drug demand growth

  • ▪Cardinal Health's fourth-quarter performance was driven by sustained demand for branded and specialty drugs
  • ▪Drug distributors are experiencing rising demand for biosimilars and high-margin medicines treating complex conditions such as cancer, rheumatoid arthritis, and autoimmune diseases

Pharmaceutical Solutions revenue increase

  • ▪The sales growth in Cardinal Health's Pharmaceutical and Specialty Solutions unit was fueled by demand for branded and specialty drugs
  • ▪Cardinal Health's Pharmaceutical and Specialty Solutions unit, its largest unit by revenue, reported a 6% year-over-year sales increase to $55.4 billion during the fourth quarter

AdaptHealth diabetes business acquisition

  • ▪The acquisition of AdaptHealth's diabetes business expanded Cardinal Health's home care business and broadened its reach in diabetes care using its direct-to-consumer distribution platform
  • ▪The acquisition of Strive Medical enhanced Cardinal Health's position in the urology market
  • ▪Cardinal Health acquired AdaptHealth's diabetes health business and medical supply provider Strive Medical in July 2026 in separate deals totaling approximately $360 million

2 sources

CNBC
We're lifting our price target on Cardinal Health after issuing rosy profit guidance
View source article
Reuters
Cardinal Health forecasts full-year profit above estimates on specialty drug strength | Reuters
View source article

Featured stories

View more in Drug supply chain

Jensen Huang resigns as Nvidia CEO amid spy affair scandal

Nov 12, 2026 · 2 sources

Story comments

Loading comments…

Related entities

United States

Topics

Drug supply chainWall StreetPharma

Featured stories

View more in Drug supply chain

Jensen Huang resigns as Nvidia CEO amid spy affair scandal

Nov 12, 2026 · 2 sources